Related Experiment Video
Updated: Aug 15, 2025

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
MicroRNA-124 expression in Kupffer cells modulates liver injury by targeting IL-6/STAT3 signaling
Jinyu Wang1, Xueyun Zhang1, Jiajia Han1
1Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Shanghai Institute of Infectious Diseases and Biosecurity, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
Abstract:
MicroRNA-124 (miR-124) is related to liver injury due to chronic hepatitis B (CHB) and hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF). However, the mechanism whereby miR-124 regulates liver inflammation remains unknown. In this study, we show that serum miR-124 serves as a compensatory predictive factor for organ failure and the 28-day prognosis of patients with HBV-ACLF. Moreover, within a mouse model of concanavalin A-induced acute liver injury, miR-124 is highly expressed in Kupffer cells. Overexpression of miR-124 significantly decreases interleukin-6 (IL-6) secretion, and relieves pathological liver necrosis to a great extent. Mechanistically, miR-124 directly targets the 3'-untranslated region of signal transducer and activator of transcription 3 (STAT3) and inhibits IL-6/STAT3 signaling, which reduces pro-inflammatory Kupffer cell polarization. Collectively, our findings suggest that miR-124 can potentially serve as a predictive biomarker for HBV-ACLF prognosis and may represent a promising therapeutic target for relieving severe liver injury resulting from cytokine storms.
Insights
Serum microRNA-124 (miR-124) predicts prognosis in hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF). MiR-124 reduces liver inflammation by inhibiting IL-6/STAT3 signaling, offering a potential therapeutic target for liver injury.
Area of Science:
- Hepatology
- Immunology
- Molecular Biology
Background:
- Chronic hepatitis B (CHB) and hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) are significant causes of liver injury.
- The precise mechanisms by which microRNA-124 (miR-124) influences liver inflammation in these conditions are not fully understood.
Purpose of the Study:
- To investigate the role of miR-124 in liver inflammation and its potential as a predictive biomarker in HBV-ACLF.
- To elucidate the molecular mechanism through which miR-124 regulates liver injury.
Main Methods:
- Analysis of serum miR-124 levels in patients with HBV-ACLF.
- Utilizing a mouse model of concanavalin A-induced acute liver injury.
- Investigating the effect of miR-124 overexpression on interleukin-6 (IL-6) secretion and liver necrosis.
- Identifying the direct target of miR-124 using molecular assays.
Main Results:
- Serum miR-124 levels were found to be a compensatory predictive factor for organ failure and 28-day prognosis in HBV-ACLF patients.
- In a mouse model, miR-124 was highly expressed in Kupffer cells and its overexpression reduced IL-6 secretion and liver necrosis.
- MiR-124 was shown to directly target the 3'-untranslated region of signal transducer and activator of transcription 3 (STAT3), inhibiting the IL-6/STAT3 signaling pathway.
- This inhibition led to reduced pro-inflammatory Kupffer cell polarization.
Conclusions:
- MiR-124 shows potential as a predictive biomarker for HBV-ACLF prognosis.
- MiR-124 may serve as a therapeutic target for mitigating severe liver injury associated with cytokine storms in HBV-ACLF.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
The JAK-STAT Signaling Pathway
MicroRNAs

